Partner, Latham & Watkins

Eric Greig, a partner in the Washington, D.C. office of Latham & Watkins, focuses his practice on healthcare regulatory, litigation and transactional matters involving the medical device, pharmaceutical, clinical laboratory and healthcare provider industries.

Mr. Greig provides counsel on a variety of healthcare regulatory and transactional matters, focusing primarily on issues involving the Centers for Medicare and Medicaid Services (CMS), the HHS Office of Inspector General (OIG) and commercial insurers. He advises clients in the development and execution of third-party reimbursement strategies for new and existing technologies; counsels on compliance with Medicare billing policies, fraud and abuse laws, and federal and state “sunshine” laws; and advocates on behalf of healthcare providers and suppliers in connection with regulatory matters before CMS as well as government audits and investigations.

Mr. Greig also advises private equity firms, investment banks, commercial lenders, and healthcare and life science companies on regulatory issues related to mergers and acquisitions, IPOs and financing the United States.

Mr. Greig is a member of the American Health Lawyers Association and the American Bar Association Health Law Section.

Follow us on: